middle.news
How Nyrada’s Xolatryp Shields Cells to Combat Brain and Heart Injury
10:11am on Tuesday 16th of September, 2025 AEST
•
Healthcare
Read Story
How Nyrada’s Xolatryp Shields Cells to Combat Brain and Heart Injury
10:11am on Tuesday 16th of September, 2025 AEST
Key Points
Xolatryp reduces mitochondrial calcium ion overload in traumatic brain injury models
Preclinical evidence supports Xolatryp’s mechanism in mitigating secondary brain and heart injury
Mitochondrial protection linked to reduced reactive oxygen species damage
Phase IIa clinical trial for acute myocardial infarction patients on track for early 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Nyrada (ASX:NYR)
OPEN ARTICLE